AstraZeneca announced that its CEO, Pascal Soriot, earned £17.7 million in 2025, an increase of over 6% compared to 2024, when he earned £16.6 million. This includes annual bonuses of £4.3 million and long-term shares worth £11.6 million. The company reported a profit increase of 40% and a rise in shares over the last 12 months, and Soriot could benefit from an additional salary increase in 2026, with a possible maximum package of £19.6 million. Although AstraZeneca is expanding its operations in the US and China and investing in weight loss drugs, it has reduced investments in the UK, canceling a £450 million expansion for a vaccine facility last year. Soriot has consistently been named the highest-paid CEO in the UK, earning 176 times the average salary of an AstraZeneca employee.
Sources
Latest News
08:44
The president of Vulturii Fărcășești, the first reaction after the sanctions from the match-fixing case
08:35
Fatal accident on DN 13 A, in Harghita County: a man died, and two other people were injured / A SMURD helicopter was requested
08:15
Drone attack in Ryazan, Russia: Industrial facilities caught fire / Governor Pavel Malkov reported six people injured
08:15
Russia reacts after the downing of drones in Romania. Russia calls the downing of the drones "staged incidents" and threatens Romania.
07:56
EXCLUSIVE | July 29, 2026. Trends in online searches / last 24 hours
See more news